Showing results (931-940 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|January 18, 2014
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and managementMarco Tuccori, Sabrina Montagnani, Stefania Mantarro, et al.CNS Drugs|May 30, 2014
Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventionsSahil Gupta, Irfan Ahsan, Naeem Mahfooz, et al.CNS Drugs|July 2, 2014
Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugsEmanuela Offidani, Giovanni A Fava, Nicoletta SoninoCNS Drugs|September 29, 2012
Volatile substance misuse : clinical considerations, neuropsychopharmacology and potential role of pharmacotherapy in managementEric L Garland, Matthew O HowardCNS Drugs|August 21, 2012
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysisMarc De Hert, Weiping Yu, Johan Detraux, et al.CNS Drugs|August 2, 2012
Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studiesSusan A VanMeter, Sarah T Kavanagh, Samantha Warren, et al.CNS Drugs|July 6, 2012
Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorderChristopher Steer, Jan Froelich, César A Soutullo, et al.CNS Drugs|February 27, 2015
Does ketamine have anti-suicidal properties? Current status and future directionsRebecca B Price, Sanjay J MathewCNS Drugs|July 21, 2022
Antiseizure Drugs and Movement DisordersMichel Sáenz-Farret, Marina A J Tijssen, Dawn Eliashiv, et al.Pageof 211